There is a relative paucity of data quantifying the complication rate associated with ICD generator replacement, along with attendant risk factors. Both a replacement indication and number of previous pocket procedures have been identified as risk factors for perioperative complications, particularly infection. 9, 11 Previous studies on ICD implantation complication rates have focused on infection rates, predominantly with de novo implantation. [13] [14] [15] Little is known about the rates and predictors of complications after ICD replacement. Patients who undergo ICD replacement often have significant cardiac conditions and noncardiac comorbidities and may therefore be at higher risk of developing complications from the procedure than has been demonstrated in randomized trials. 16 Complications arising from ICD replacement are not only important from the standpoint of patient care but also add significantly to length of hospital stay and increase health care costs. 7 In this study, we examined the outcomes of patients undergoing defibrillator replacement in the Ontario Implantable Cardioverter Defibrillator (ICD) Database, a comprehensive population-based, multicenter prospective registry of patients undergoing device implantation. We examined the frequency of complications and their predictors. We hypothesized that the burden of complications after defibrillator replacement would be predicted by patient, device, and physician characteristics.
Methods

Patients
The study assessed patients undergoing replacement of an ICD generator in the Ontario ICD Database from February 2007 to August 2009. The design and methodology of the Ontario ICD Database have been published elsewhere, along with the outcome of de novo ICD implantation. 13, 17 This project is an ongoing prospective registry of all patients (age Ն18 years) undergoing defibrillator implantation in Ontario, Canada, which has been mandated by the Ontario Ministry of Health and Long-Term Care. Patient data are collected at initial evaluation, at the time of ICD implant, and at each follow-up visit in the ICD clinic. As a "prescribed entity" under Ontario health information privacy legislation, the coordinating center (Institute for Clinical Evaluative Sciences), is allowed to collect data on all patients in this registry without informed consent, conditional on adequate privacy protection, and therefore all patients had their data entered into the database without participation bias. 8 Disclosure of events that occurred in Յ5 individuals is not reported for privacy purposes but is included in the analysis and reported in summary data.
Data Sources
Details of the primary data collection process for the Ontario ICD Database have been described previously. 17 Briefly, data in the ICD database were collected by the local electrophysiologist and a trained research coordinator at defibrillator implantation centers, who entered the data into a secure, firewall-and password-protected web-based registry at the Institute for Clinical Evaluative Sciences. Data were collected on patient characteristics, indication for the defibrillator, comorbidities, left ventricular ejection fraction (LVEF), and implant-related data. We also collected clinical and devicerelated events occurring in follow-up, with data entered at the implanting hospital or peripheral ambulatory device clinics. Data quality was continually assessed by regular review and correspondence with study sites, automated range checks, notification of uncoded data elements, and ongoing random site audits. 17 Deaths were identified by clinical follow-up at routine defibrillator clinic visits and via the Registered Persons Database linked using the patient's unique encrypted health card number. Vital status data were available for all study patients. Ethics approval was obtained from the Sunnybrook Health Sciences Centre before study initiation. A complete list of participating ICD implant and follow-up sites is shown in online-only Data Supplement Appendix 1.
Complications
At defibrillator clinic visits after device implant, patients were routinely evaluated for any device-related complications that occurred within 45 days of the procedure using a standard checklist. 17 Since the date of the initial postreplacement clinic visit could vary between centers, we cross-referenced the recorded dates of complications from subsequent clinic visits and counted those events occurring temporally within 45 days after implant. Complications were adjudicated by the local electrophysiologist and a trained research coordinator at defibrillator implantation centers, who entered the data into a secure, firewall-and password-protected web-based registry at the Institute for Clinical Evaluative Sciences. These complications were categorized as major or minor (see online-only Data Supplement Appendix 2), based on prospectively defined definitions arrived at by consensus of electrophysiologists from all participating hospitals, guided by a prior report. 9, 11 Major complications included those that lead to hospitalization, substantive parenteral therapy, or the need for a surgical intervention. Complications were generally distinguished from minor complications if a surgical intervention was necessary. Major complications included death unless otherwise specified. Complications were also categorized as mechanical if they stemmed from a direct mechanical effect of surgery such as hematoma or pneumothorax or clinical based on new or worsening comorbidities (online-only Data Supplement Appendix 2). Patients were deemed to have had "any complication" if they had at least 1 of a major or minor complication.
Factors Analyzed for Association With Complications
The variables considered in the univariate analysis included age, sex, prior ventricular tachycardia (VT), and primary disease etiology (eg, ischemic, nonischemic cardiomyopathy, or other conditions such as congenital heart disease or hypertrophic cardiomyopathy). Cardiac factors included prior myocardial infarction, revascularization procedure, heart failure, New York Heart Association (NYHA) class, preexisting pacemaker system, and atrial fibrillation. Noncardiac factors included general laboratory measures (eg, serum creatinine concentration, estimated glomerular filtration rate, serum sodium, hemoglobin) and comorbidities. Medications were also examined, including angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB), ␤-adrenoreceptor antagonists, loop diuretic, antiplatelet or anticoagulant drug, amiodarone, and class IC or other class III antiarrhythmic drugs. Diagnostic investigations included QRS duration (Ͼ140 versus Յ140 ms), LVEF (Յ20, 21 to 35, or Ͼ35%), left ventricular dimension in end-systole or end-diastole, and left atrial size. Device type was also examined (eg, dual-chamber, cardiac resynchronization device [CRT-D], or singlechamber device). Physician procedure volume and surgeon versus nonsurgeon were physician factors that were examined.
Statistical Analysis
Univariate Cox regression analysis was performed to determine predictors of time to complication after ICD implant (online-only Data Supplement). Potential predictors with PϽ0.25 on univariate analysis were included in the multivariable multiple regression model using a backwards variable elimination with retention of potentially clinically important variables, and predictors were retained in the multivariable model based on clinical and statistical significance (PϽ0.05). All multivariable models included age irrespective of its statistical significance, because of the potential of this variable to account for complications.
The association of complications excluding death (eg, major nondeath complications) with mortality was determined using complication status as a time-dependent covariate in Cox regression analysis. In the time-varying model, patients were considered complication-free until a complication occurred, at which time they were reclassified. Complications occurring more than 45 days after implant were not included in the determination of exposure status. The association of complications with death occurring up to 180 days after defibrillator implantation was adjusted for age, sex, and ICD type. Continuous data are presented as meanϮSD and compared using Student t test. Categorical variables were compared using the 2 test, Fisher exact test, or the Mantel-Hanszel test for trend. Exact 95% confidence intervals were determined using published methods. All analyses were performed using SAS version 9.1 (Cary, NC). The authors had full access to the data and take full responsibility for its integrity. All authors have read and agree to the manuscript as written.
Results
ICD replacement was performed in 1081 of 5176 patients undergoing ICD implantation at 10 implant and 18 follow-up centers (20.8%, Table 1 ). Demographic and clinical characteristics of these patients are reported in Table 2 ). Forty-seven major complications occurred in 28 patients (2.6%), most commonly lead revision, infection, electrical storm, and pulmonary edema. There were no procedure-related deaths. Fourteen patients had 2 or more major complications. Forty-one minor complications occurred in 25 patients (2.3%), most commonly incisional infection and pocket hematoma. Eleven patients had 2 or more minor complications. The time to occurrence of any repeated procedures (eg, lead revision, generator replacement, hematoma evacuation, etc) is shown in Figure 1 , demonstrating that the majority of repeat procedures occurred within the first 2 months of the replacement ICD procedure. Stroke occurred in 6 patients, 4 of whom had defibrillation threshold (DFT) testing (67% DFT rate in stroke patients versus 25.1% DFT rate in 1075 patients without stroke, Pϭ0.02).
Univariate predictors of complications are summarized in Table 3 . Patient factors that were associated with risk of complications included presence of coronary artery disease and severity of heart failure. System factors associated with risk included a more complex device system, particularly CRT and addition of leads, and a decreased operator procedure volume (Figure 2 ). The sole physician risk factor was operator procedure volume, with lower complication in highvolume implanters. Two variables were independent risk factors for major complications: severity of angina and the number of additional device surgeries (Table 4) . Minor complications were independently associated with patient use of antiarrhythmic drugs and low operator procedure volume.
Overall complication risk factors were a combination of these variables.
With respect to the effect of lead addition contribution to complications, electrical storm occurred in 0.99% of 399 lead addition cases and 0.59% of 674, in which a lead was not added (Pϭ0.46). Upgrade with addition of any lead was positively associated with complications (6.6% of 397 pa- 
Discussion
The current study found that complications occurred in a significant proportion of patients undergoing ICD replacement in a systematic population-based registry. The clinical 
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utility of the findings include the provision of benchmarks for quality improvement and informed consent. Generator change is a higher risk procedure than new implants, which argues for developing longer-lasting devices, minimizing unnecessary battery drain, and replacing normally functioning advisory components, particularly when the incremental benefit of a discretionary procedure such as system upgrade is known. This suggests that clinicians and researchers should consider strategies to minimize the need for device replacement, particularly because most devices are implanted for primary prevention. Risk factors associated with complications after ICD replacement include the presence of angina, low implanter procedural volume, and antiarrhythmic therapy. The number of repeat procedures was also associated with increased major complication risk. Previous comparative studies have focused on series of patients primarily undergoing new ICD implantation, largely reporting complications during acute hospitalization, without systematic posthospitalization follow-up.
The Canadian Heart Rhythm Society has previously reported on a retrospective series that involved 533 ICDs that were replaced because of an advisory, which demonstrated an overall complication rate of 8.1%. 9 This unexpectedly high complication rate was associated with major complications in 2.0% of patients, including death in 2 patients. In the absence of preceding data, this figure considerably exceeded expectations of the arrhythmia community. Subsequent analysis in 451 patients demonstrated that number of previous pocket procedures and combined operators (consultant and trainee) were risk factors associated with complications. 11 A voluntary German ICD registry focusing on new implants reported rates of specific complications and found that pocket hematoma, chronic pain, and lead and device dislodgments leading to operative revisions were the most common events, with reoperation in 3.0%. This study was limited by loss to follow-up in 24% of patients within 3 months and did not examine risk factors for complications. 18 A larger multicenter study reported that lead-related and pocket-related complications occurred in 2.1% and 1.8%, respectively, but predictors of these events were not determined. 19 The National Cardiovascular Data Registry ICD Registry reported in-hospital complication rates of 1.3% for major complications and 3.6% for any complication but differed from the current study because reporting was not mandatory from all hospitals and lead complications were not included. 14 Recently, the REPLACE registry reported a 4.0% complication rate in 1031 patients undergoing generator replacement and 15.3% in 713 patients with replacement and a lead addition. 12 This prospective registry reported that ICDs and particularly CRT ICDs were associated with a greater risk of complications, consistent with the current study that found a higher complication in upgrade and CRT patients.
Administrative databases focusing on new implants have reported different event rates and predictors. Using Medicare administrative databases, 90-day complications were reported to have occurred in 14.2% of patients. 15 Many of the major complications in this study overlapped with ours, but the predictors were predominantly noncardiac comorbidities. A study of Medicare beneficiaries found that in-hospital complications occurred in 10.8% of ICD recipients, with resultant increases in length of hospital stay and costs. 20 The current study differed because we considered an early postprocedural time window, which reflects complications related to device replacement, and furthermore, we used clinically obtained data on predictors and events.
The current study is novel because the data were collected in a prospective, population-based registry, with detailed longitudinal follow-up. The current study was derived from a registry that was mandated by the administrator of health care services in Ontario, and participation from all ICD implanting centers was required. Thus, the current study was not subject to volunteer bias and was able to study all patients. Finally, a wide array of potential clinical predictors and major and minor complications, including death, were systematically evaluated.
The finding of clustering of multiple complications in individual patients is interesting, suggesting that patients who have had a complication may have more than 1 complication from some primary trigger or that their underlying comorbidities place them at high risk of simultaneous or successive complications. The current registry does not collect sufficient detail to explore this hypothesis generating finding in further detail, but this is an important observation that warrants further study. Detailed temporal analysis of a sufficient number of patients is necessary to better understand this relationship.
The association of complications with subsequent mortality is of interest, though the mechanism of association is speculative. A similar association was noted in the larger sample of de novo implants in the Ontario registry, so the findings are unlikely to be spurious. 13 The early mortality effects of complications may be the direct "mechanical" consequence of the procedure, such as infection, pneumothorax, or perforation, that are not well tolerated. These risks probably are largely related to procedural complexity, reflected in system configuration risk, and operator expertise, reflected in procedural volume. The second contributor is the patient; the physiological duress of even minor surgery may exacerbate comorbidities, particularly heart failure, which contributes significantly to reduced survival. 21 The use of antiarrhythmic medication reflects underlying abnormalities in the electric substrate, which may have conferred an increase in clinical complications by this mechanism. This may well be spurious because the strength of association was greatest for minor complications that were not rhythm-related. Few studies have systematically examined the predictors of complications in this population using multivariable analysis. These data suggest that complications are driven by the 3 major components that contribute risk: device, physician, and patient factors. This may be most relevant for patients with complex device systems, particularly heart failure patients. The finding that low procedural volume implanters have higher complication rates is consistent with other series, both in ICD insertion and other cardiovascular procedures. 15, [22] [23] [24] 
Limitations
Several limitations to the current study warrant mention. Several operator characteristics were not explored, including the role of the trainee, the location of the procedure, and the number of years in practice of the operator. These and other factors are undoubtedly important but are beyond the scope of data currently being collected in the registry. Trainees are involved in the majority of procedures in Ontario, and their presence should if anything attenuate the effect of the low volume implanter. Nonetheless, this finding warrants rigorous scrutiny in a prospective fashion. The risk factors identified in the current study are biologically plausible, but the mechanism by which they confer risk is not identified. Although this is a large prospective series of replacement patients, the number of events and patients affected is modest, limiting the power of current analysis techniques to detect all but strong associations. Further study in larger populations is needed to explore these less compelling risk factors. Last, extending the follow-up may also detect latent complications such as indolent infection.
Conclusions
Complications occurred in a significant proportion of patients undergoing ICD replacement. Risk factors for complications after ICD replacement include the presence of angina, low implanter procedural volume, the number of repeated procedures, and antiarrhythmic therapy. Complications may be associated with increased risk of subsequent mortality.
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